We are live on
!
Find out more
PCM
Portolan Capital Management Portfolio holdings
AUM
$1.88B
1-Year Est. Return
115.74%
This Fund
S&P 500
This Quarter
Est. Return
-14.21%
1 Year Est. Return
+115.74%
3 Year Est. Return
+581.85%
5 Year Est. Return
+1,047.01%
10 Year Est. Return
+13,266.68%
AUM
$993M
AUM Growth
-$261M
(-21%)
Cap. Flow
-$46M
Cap. Flow
% of AUM
-4.64%
Top 10 Holdings %
Top 10 Hldgs %
24.28%
Holding
176
New
40
Increased
34
Reduced
46
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stride
LRN
|
+$19.4M |
| 2 |
Kroger
KR
|
+$18.4M |
| 3 |
Check Point Software Technologies
CHKP
|
+$17.3M |
| 4 |
United Therapeutics
UTHR
|
+$17.2M |
| 5 |
Nomad Foods
NOMD
|
+$17M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TGH
Textainer Group Holdings limited
TGH
|
+$19.9M |
| 2 |
ZIM Integrated Shipping Services
ZIM
|
+$15.9M |
| 3 |
Vistra
VST
|
+$15.4M |
| 4 |
TRTN
Triton International Limited
TRTN
|
+$15.2M |
| 5 |
Andersons Inc
ANDE
|
+$15.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.3% |
| 2 | Healthcare | 14.34% |
| 3 | Consumer Discretionary | 13.91% |
| 4 | Consumer Staples | 12.35% |
| 5 | Industrials | 11.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Euronet Worldwide
EEFT
$2.7B
| $12.6M | 1.27% |
124,967
+77,514
| +163% | +$9.18M |
|
|
CHRA
27
DELISTED
Charah Solutions, Inc Common Stock
CHRA
| $12.5M | 1.26% |
334,992
-24,205
| -7% | -$870K |
|
28
Lantronix
LTRX
$266M
| $12.4M | 1.25% |
2,303,371
+2,253,371
| +4,507% | +$13M |
|
29
Alta Equipment Group
ALTG
$244M
| $12M | 1.21% |
1,342,921
-231,927
| -15% | -$2.54M |
|
30
Leidos
LDOS
$17.3B
| $11.9M | 1.19% |
117,733
+21,988
| +23% | +$2.28M |
|
|
DSKE
31
DELISTED
Daseke, Inc. Common Stock
DSKE
| $11.8M | 1.19% |
1,846,188
-786,482
| -30% | -$6.01M |
|
32
Tecnoglass Holdings Inc.
TGLS
$1.96B
| $11.1M | 1.11% |
630,276
-275,097
| -30% | -$5.84M |
|
33
Expedia Group
EXPE
$37.3B
| $10.7M | 1.08% |
+113,174
| New | +$16M |
|
|
PINC
34
DELISTED
Premier
PINC
| $10.7M | 1.07% |
+299,115
| New | +$10.9M |
|
35
Sony
SONY
$138B
| $10.5M | 1.06% |
642,515
-3,345
| -0.5% | -$59.2K |
|
36
Meta Platforms (Facebook)
META
$1.51T
| $9.99M | 1.01% |
61,986
+22,795
| +58% | +$4.4M |
|
37
BlueLinx
BXC
$706M
| $9.63M | 0.97% |
144,123
-125,588
| -47% | -$9.44M |
|
38
Fidelity National Information Services
FIS
$22.1B
| $9.62M | 0.97% |
104,894
+42,288
| +68% | +$4.2M |
|
39
Amphastar Pharmaceuticals
AMPH
$916M
| $9.56M | 0.96% |
+274,889
| New | +$9.81M |
|
40
Saic
SAIC
$5.35B
| $9.55M | 0.96% |
102,556
+51,193
| +100% | +$4.48M |
|
41
STAAR Surgical
STAA
$1.21B
| $9.38M | 0.94% |
132,179
+20,381
| +18% | +$1.31M |
|
42
Custom Truck One Source
CTOS
$2.37B
| $9.3M | 0.94% |
1,661,210
+212,701
| +15% | +$1.36M |
|
43
Twilio
TWLO
$36.6B
| $9.13M | 0.92% |
108,904
+58,183
| +115% | +$6.51M |
|
44
L3Harris
LHX
$53.4B
| $8.83M | 0.89% |
+36,526
| New | +$8.82M |
|
45
Harvard Bioscience
HBIO
$29.2M
| $8.83M | 0.89% |
245,186
-7,493
| -3% | -$338K |
|
46
Health Catalyst
HCAT
$128M
| $8.07M | 0.81% |
557,227
+279,820
| +101% | +$4.77M |
|
47
SLM Corp
SLM
$5.15B
| $7.81M | 0.79% |
+490,028
| New | +$8.48M |
|
48
Thermo Fisher Scientific
TMO
$220B
| $7.7M | 0.78% |
14,180
-6,614
| -32% | -$3.64M |
|
49
F5
FFIV
$22.7B
| $7.68M | 0.77% |
50,183
+1,246
| +3% | +$217K |
|
|
SMAR
50
DELISTED
Smartsheet Inc.
SMAR
| $7.64M | 0.77% |
+243,181
| New | +$10.1M |
|
Similar funds
JPG
SGF
TF
VC
PCP
EPW
P3I
LPU
Portolan Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, Portolan Capital Management held 176 positions worth $993M, down 21% from $1.25B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Portolan Capital Management withdrew a net $46M in Q2 2022, closing 53 positions and reducing 46 holdings. Its most notable exit was Textainer Group Holdings limited, an estimated $19.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Portolan Capital Management opened a new position in Stride worth $21.4M.
- Portolan Capital Management's largest Q2 2022 buy was Stride: 525,137 shares worth $21.4M.
- Portolan Capital Management added most to e.l.f. Beauty in Q2 2022, an estimated $14.2M increase.
- Portolan Capital Management's biggest Q2 2022 reduction was Vistra, cutting an estimated $15.4M.
- Portolan Capital Management fully exited Textainer Group Holdings limited in Q2 2022, selling an estimated $19.9M.
- Portolan Capital Management's ten largest holdings make up 24% of its $993M portfolio in Q2 2022.
- Portolan Capital Management opened 40 new positions and closed 53 in Q2 2022.
- Portolan Capital Management's portfolio value fell 21% quarter-over-quarter to $993M.
Based on Portolan Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.